17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Pharmaceutical and medicinal significance of sulfur (S VI)-Containing motifs for drug discovery: A critical review

      review-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Sulfur (S VI) based moieties, especially, the sulfonyl or sulfonamide based analogues have showed a variety of pharmacological properties, and its derivatives propose a high degree of structural diversity that has established useful for the finding of new therapeutic agents. The developments of new less toxic, low cost and highly active sulfonamides containing analogues are hot research topics in medicinal chemistry. Currently, more than 150 FDA approved Sulfur (S VI)-based drugs are available in the market, and they are widely used to treat various types of diseases with therapeutic power. This comprehensive review highlights the recent developments of sulfonyl or sulfonamides based compounds in huge range of therapeutic applications such as antimicrobial, anti-inflammatory, antiviral, anticonvulsant, antitubercular, antidiabetic, antileishmanial, carbonic anhydrase, antimalarial, anticancer and other medicinal agents. We believe that, this review article is useful to inspire new ideas for structural design and developments of less toxic and powerful Sulfur (S VI) based drugs against the numerous death-causing diseases.

          Graphical abstract

          Highlights

          • More than 150 sulfonamide drugs are available in the market.

          • Sulfonamide based drugs are huge range of therapeutic applications.

          • We collected 337 potent bioactive sulfonyl or sulfonamide bearing heterocyclic analogues.

          • We briefly explain the structure activity relationship of all molecules to develop novel drugs.

          Related collections

          Most cited references214

          • Record: found
          • Abstract: found
          • Article: not found

          Molecular characterization of a peripheral receptor for cannabinoids.

          The major active ingredient of marijuana, delta 9-tetrahydrocannabinol (delta 9-THC), has been used as a psychoactive agent for thousands of years. Marijuana, and delta 9-THC, also exert a wide range of other effects including analgesia, anti-inflammation, immunosuppression, anticonvulsion, alleviation of intraocular pressure in glaucoma, and attenuation of vomiting. The clinical application of cannabinoids has, however, been limited by their psychoactive effects, and this has led to interest in the biochemical bases of their action. Progress stemmed initially from the synthesis of potent derivatives of delta 9-THC, and more recently from the cloning of a gene encoding a G-protein-coupled receptor for cannabinoids. This receptor is expressed in the brain but not in the periphery, except for a low level in testes. It has been proposed that the nonpsychoactive effects of cannabinoids are either mediated centrally or through direct interaction with other, non-receptor proteins. Here we report the cloning of a receptor for cannabinoids that is not expressed in the brain but rather in macrophages in the marginal zone of spleen.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Structure of a cannabinoid receptor and functional expression of the cloned cDNA.

            Marijuana and many of its constituent cannabinoids influence the central nervous system (CNS) in a complex and dose-dependent manner. Although CNS depression and analgesia are well documented effects of the cannabinoids, the mechanisms responsible for these and other cannabinoid-induced effects are not so far known. The hydrophobic nature of these substances has suggested that cannabinoids resemble anaesthetic agents in their action, that is, they nonspecifically disrupt cellular membranes. Recent evidence, however, has supported a mechanism involving a G protein-coupled receptor found in brain and neural cell lines, and which inhibits adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner. Also, the receptor is more responsive to psychoactive cannabinoids than to non-psychoactive cannabinoids. Here we report the cloning and expression of a complementary DNA that encodes a G protein-coupled receptor with all of these properties. Its messenger RNA is found in cell lines and regions of the brain that have cannabinoid receptors. These findings suggest that this protein is involved in cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Synopsis of some recent tactical application of bioisosteres in drug design.

                Bookmark

                Author and article information

                Contributors
                Journal
                Eur J Med Chem
                Eur J Med Chem
                European Journal of Medicinal Chemistry
                Elsevier Masson SAS.
                0223-5234
                1768-3254
                22 November 2018
                15 January 2019
                22 November 2018
                : 162
                : 679-734
                Affiliations
                [1]Department of Pharmaceutical Engineering, School of Chemistry, Chemical Engineering and Life Science, Wuhan University of Technology, 205 Luoshi Road, Wuhan, 430070, PR, China
                Author notes
                []Corresponding author. rakeshasg@ 123456gmail.com
                [∗∗ ]Corresponding author. qinhuali@ 123456whut.edu.cn
                Article
                S0223-5234(18)30971-1
                10.1016/j.ejmech.2018.11.017
                7111228
                30496988
                0bc4b38a-cb43-49a5-8d8b-c508faeee308
                © 2018 Elsevier Masson SAS. All rights reserved.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                : 26 July 2018
                : 17 October 2018
                : 7 November 2018
                Categories
                Article

                Pharmacology & Pharmaceutical medicine
                sulfonyl (svi),sulfonamides,sar,docking,biological activities

                Comments

                Comment on this article

                scite_

                Similar content205

                Cited by102

                Most referenced authors3,849